XTX Topco Ltd - BOLT BIOTHERAPEUTICS INC ownership

BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 38 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
XTX Topco Ltd ownership history of BOLT BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2024$17,956
-16.3%
12,826
-33.0%
0.00%
-60.0%
Q4 2023$21,450
+25.9%
19,152
+43.9%
0.01%
+66.7%
Q2 2023$17,036
-72.1%
13,309
+6.9%
0.00%
-91.4%
Q4 2021$61,00012,4530.04%
Other shareholders
BOLT BIOTHERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,891,467$1,418,6001.09%
Nan Fung Group Holdings Ltd 1,166,952$875,2140.93%
TANG CAPITAL MANAGEMENT LLC 3,812,773$2,859,5800.29%
Acuitas Investments, LLC 630,507$472,8800.25%
Vivo Capital, LLC 3,521,291$2,640,9680.24%
Newtyn Management, LLC 1,363,234$1,022,4250.19%
Samsara BioCapital, LLC 1,049,153$786,8650.16%
Sofinnova Investments, Inc. 2,754,437$2,065,8280.11%
Board of Trustees of The Leland Stanford Junior University 719,546$539,6590.04%
ADAR1 Capital Management, LLC 185,999$139,4990.03%
View complete list of BOLT BIOTHERAPEUTICS INC shareholders